Innovative local therapies in lung cancer

G. Massard (Strasbourg, France)

Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Session: PG11 Modern approaches in lung cancer diagnostics and therapy
Session type: Postgraduate Course
Number: 117

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). Innovative local therapies in lung cancer. International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Innovative systemic lung cancer therapies
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Cardiovascular effects of innovative therapies in lung cancer
Source: Eur Respir Monogr 2020; 88: 154-166
Year: 2020


New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


New and emerging targeted treatments in advanced lung cancer
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016


Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015


Lung disease induced by newer therapies for lung cancer: an update
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006


Immunology-based therapeutic strategies in lung cancer and mesothelioma
Source: International Congress 2014 – Beyond tyrosine kinase inhibition: promising new developments in molecular oncology
Year: 2014



Genetics and tailored treatment of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013

Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018

Current place and future of immunotherapy in lung cancer
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016


PG11 Modern approaches in lung cancer diagnostics and therapy
Source: Paris 2018 - Educational material
Year: 2018

Milestones in the management of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Current challenges in the management of nonsmall cell lung cancer brain metastases
Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019
Year: 2020